what is the average weekly weight loss on tirzepatide Who Right For? A Guide to Patient Selection Body weight loss with tirzepatide

This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

The pharmacokinetics of semaglutide across multiple trials offer a surprisingly clean window into how this molecule and this biology actually works.

Patients want to lose extra fat, but not their muscle

Tirzepatide for Obesity

Objective Investigate the association between GLP-1RAs use and intestinal obstruction in a large cohort of patients with type 2 diabetes mellitus (T2DM) in the U.S

Stat News called for dropping GLP-1 as a single target